Recurrent Fetal Loss and Antiphospholipid Antibodies: Clinical and Therapeutic Aspects
Recurrent fetal losses indicate screening for antiphospholipid antibodies, especially after the third consecutive fetal loss, or when they occur after 12 weeks gestation or when the mother presents with thrombosis or other ailments of antiphospholipid syndrome. Fetal loss may be caused by thromboses...
Saved in:
Main Authors: | O. Blétry (Author), A.-M. Piette (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
1997-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THE ROLE OF CIRCULATING ANTIPHOSPHOLIPID ANTIBODIES IN THE FETAL LOSS SYNDROME DEVELOPMENT
by: M. S. Selkhadzhieva
Published: (2016) -
Prevention of recurrent fetal growth retardation in patients with circulating antiphospholipid antibodies and genetic thrombophilia
by: E. A. Orudzhova, et al.
Published: (2022) -
Cell Damage at the Origin of Antiphospholipid Antibodies and Their Pathogenic Potential in Recurrent Pregnancy Loss
by: Véronique Piroux, et al.
Published: (1997) -
Antiphospholipid antibodies, genetic thrombophilia and fetal growth retardation
by: E. A. Orudzhova
Published: (2022) -
Antiphospholipid antibody: laboratory, pathogenesis and clinical manifestations
by: T. Ziglioli, et al.
Published: (2011)